Radius Fracture Anesthesia and Rehabilitation (RADAR) (RADAR)

October 26, 2022 updated by: Bengt Nellgård, Sahlgrenska University Hospital, Sweden
Distal fracture of the radial bone is the commonest fracture and is also connected to osteoporosis. Normally the operation is performed under neuroaxial blockade and sedation. When the blockade rapidly vanish many patients experience a rebound pain much severer that than the actual trauma pain. If long acting local anesthetics are used this will occur during night time and many patients will go to the emergency room for pain treatment. Short acting local anesthetics may make it possible to treat patients pain in-house prior to leaving the hospital. In this study

Study Overview

Detailed Description

This investigation is a joint study involving Occupational Therapist, Orthopedic surgeons and Anesthesiologist. Distal fracture of the radial bone is the commonest fracture, mainly in elder females with osteoporosis and also obesity. Normally 75% of patients are treated with plaster after fracture repositioning. The remaining 25% are operated upon. Routinely, the operation is performed under neuroaxial blockade and sedation. When the blockade rapidly vanish many patients experience a rebound pain much severer than the initial trauma pain. If long acting local anesthetics are used the blockade will be terminated during night and many patients will go to the Emergency room for pain treatment. Short acting local anesthetics may make it possible to treat patients pain in-house prior to hospital discharge and thus reduce severe rebound pain.

In this study patients with radial fractures are included and operated upon by a standard surgical operation with plate and screws. They will receive either 1) ultra sound guided supraclavicular block long-acting (n=30) local anesthetic , 2) ultra sound guided supraclavicular block short-acing (n=60) local anesthetics or 3) general anesthesia (n=30) to provide analgesia during the operational procedure. Patients given an ultra sound guided blockade with short-acting local anesthetic (n=60) are further sub-divided into receiving either postoperative plaster/cast (n=30) or an orthosis/brace (n=30).

Patients pain will be measured by Numeric Rating scale (0 = no pain and 10 worst possible pain) during the first 7 postoperative days. The opioid consumption will be noted by personal contact intermittently by telephone and by a pain diary until day 7. Both parametric and none-parametric analysis will be conducted.

Quality of recovery will be assessed by Quality of Recovery Scale 15 at 5 occasions. Adverse effects and unplanned health care contacts will also be gathered.

After 3 days the Occupational Therapist will control the patients followed by investigations at 2, 6 12 and 52 weeks. The patients will be graded the Patient rated Wrist Evaluation (PRWE) and Michigan Outcomes Questionnaire (MHQ) Edema will be measured and strength will be measured by Jamar dynamometer, Finally, Sense of coherence will be measured by KASAM-13

Study Type

Interventional

Enrollment (Actual)

120

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • VGR
      • Molndal, VGR, Sweden, 43180
        • SahlgrenskaUH

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Understands native language
  • Cognitive intact
  • Fracture types AO 23..A and AO 23.C.1
  • Operated within 18 days from initial trauma

Exclusion Criteria:

  • Not fulfilling inclusion criterias
  • High energy trauma
  • Ligament injury

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: FACTORIAL
  • Masking: SINGLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
ACTIVE_COMPARATOR: Long acting anesthetic block/plaster
Intervention 1: Blockade will be given supraclavicularly with Long acting local Anesthetic (n=30) combined with post operative plaster immobilization.

Patients are randomized to receive; long-acting Supraclavicular plexus block or short-acting Supraclavicular plexus block or general anesthesia

Sub group randomized to plaster/cast or orthosis/brace, both having short-acting block

Other Names:
  • Long acting anesthetic block/plaster
  • Short acting anesthetic block/plaster
  • Short acting anesthetic block/orthosis
  • General Anesthesia and plaster
ACTIVE_COMPARATOR: Short acting anesthetic block/plaster
Intervention 2: Blockade will be given supraclavicularly with Short acting local anesthetic (n=30) combined with plaster immobilisation postoperatively

Patients are randomized to receive; long-acting Supraclavicular plexus block or short-acting Supraclavicular plexus block or general anesthesia

Sub group randomized to plaster/cast or orthosis/brace, both having short-acting block

Other Names:
  • Long acting anesthetic block/plaster
  • Short acting anesthetic block/plaster
  • Short acting anesthetic block/orthosis
  • General Anesthesia and plaster
ACTIVE_COMPARATOR: Short acting anesthetic block/orthotic
Intervention 3: Blockade will be given supraclavicularly with Short acting local anesthetic (n=30) and combined with orthosis for postoperative immobilisation

Patients are randomized to receive; long-acting Supraclavicular plexus block or short-acting Supraclavicular plexus block or general anesthesia

Sub group randomized to plaster/cast or orthosis/brace, both having short-acting block

Other Names:
  • Long acting anesthetic block/plaster
  • Short acting anesthetic block/plaster
  • Short acting anesthetic block/orthosis
  • General Anesthesia and plaster
ACTIVE_COMPARATOR: General Anesthesia and plaster
Intervention 4: General anesthesia wil be administered for surgical procedure combined with postoperative plaster immobilisation (n=30),

Patients are randomized to receive; long-acting Supraclavicular plexus block or short-acting Supraclavicular plexus block or general anesthesia

Sub group randomized to plaster/cast or orthosis/brace, both having short-acting block

Other Names:
  • Long acting anesthetic block/plaster
  • Short acting anesthetic block/plaster
  • Short acting anesthetic block/orthosis
  • General Anesthesia and plaster

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Rebound pain, difference in pain (NRS) at rest at 24-hours and further during the first three days after surgery between short acting block (mepivacaine) and long acting block (ropivacaine), with General Anesthesia being control group.
Time Frame: 72 hours
Postoperative pain measured by numeric pain rating scale (NRS), where 0 = no pain and 10 = worst possible pain.
72 hours
Quality of Recovery; difference in sum median and its five domains of QoR-15 score at baseline, 24 hours, 72 hours and 7 days after surgery between the two groups cast and orthosis/brace. - Anesthesiology part 2
Time Frame: 1st three postoperative days
Quality of Recovery scale 15 assessment
1st three postoperative days
Post surgery arm function - Occupational therapist
Time Frame: 12 months
Influence of immobilization by plaster or orthosis/brace
12 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Post surgery opioid requirement - Anesthesiology part
Time Frame: day 1 to 3 after surgery, including day 7 assessing immobilization (cast/brace)
daily opioid requirement mg dose
day 1 to 3 after surgery, including day 7 assessing immobilization (cast/brace)
Perioperative time events - Anesthesiology part
Time Frame: perioperatively
Perioperative time events; e.g. duration of surgery, anesthesia, Theatre time and recovery room stay
perioperatively
Postoperative Nausea and Vomiting - Anesthesiology part
Time Frame: up to 72 hours post surgery
Any experience of PONV
up to 72 hours post surgery
Unplanned health care contact - Anesthesiology part
Time Frame: 1st postoperative week
any unplanned contact with health care, emergency department visit, phone calls, GP visits etc.
1st postoperative week
Post surgery arm status 1 - Occupational therapist
Time Frame: 12 months
Clinical evaluation of post surgery arm status by a physiotherapist including: oedema,
12 months
Post surgery arm status 2 - Occupational therapist
Time Frame: 12 months
Clinical evaluation of post surgery arm status by a physiotherapist including: grip strength
12 months
Post surgery arm status 3 - Occupational therapist
Time Frame: 12 months
Clinical evaluation of post surgery arm status by a physiotherapist including sense of coherence.
12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Bengt Nellgard, MD PhD, Göteborg University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

September 3, 2018

Primary Completion (ACTUAL)

July 1, 2020

Study Completion (ACTUAL)

June 20, 2022

Study Registration Dates

First Submitted

August 22, 2018

First Submitted That Met QC Criteria

November 19, 2018

First Posted (ACTUAL)

November 21, 2018

Study Record Updates

Last Update Posted (ACTUAL)

October 27, 2022

Last Update Submitted That Met QC Criteria

October 26, 2022

Last Verified

October 1, 2022

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Radial Fracture

Clinical Trials on Long acting Supraclivicular block vs Short acting Supraclavicular block

3
Subscribe